(NASDAQ: RDNT) Radnet's forecast annual revenue growth rate of 17.08% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 9.41%, and it is also forecast to beat the US market's average forecast revenue growth rate of 16.72%.
Radnet's revenue in 2026 is $2,040,210,000.On average, 11 Wall Street analysts forecast RDNT's revenue for 2026 to be $194,418,373,125, with the lowest RDNT revenue forecast at $184,561,633,250, and the highest RDNT revenue forecast at $204,896,010,000. On average, 10 Wall Street analysts forecast RDNT's revenue for 2027 to be $215,994,543,875, with the lowest RDNT revenue forecast at $195,815,391,375, and the highest RDNT revenue forecast at $233,612,496,250.
In 2028, RDNT is forecast to generate $240,908,036,000 in revenue, with the lowest revenue forecast at $228,257,259,625 and the highest revenue forecast at $251,618,509,250.